Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Active Case Detection for Malaria in Lao PDR
NCT03783299Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Nov 2017
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Community-level PCR-based P. falciparum prevalence at 4 months, HS-RDT-based test positivity rate at 6 months and 2 more. Started Nov 2017; status: completed.
Beyond the preview
Go deeper on NCT03783299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783299.